Emerg Infect Dis. 2019 Oct;25(10):1919-1927. doi: 10.3201/eid2510.181875.
We retrospectively assessed the utility of a flow cytometry-based test quantifying the percentage of CD3+ T cells with the CD4-/CD8- phenotype for predicting tularemia diagnoses in 64 probable and confirmed tularemia patients treated during 2003-2015 and 342 controls with tularemia-like illnesses treated during 2012-2015 in the Czech Republic. The median percentage of CD3+/CD4-/CD8- T cells in peripheral blood was higher in tularemia patients (19%, 95% CI 17%-22%) than in controls (3%, 95% CI 2%-3%). When we used 8% as the cutoff, this test's sensitivity was 0.953 and specificity 0.895 for distinguishing cases from controls. The CD3+/CD4-/CD8- T cells increased a median of 7 days before tularemia serologic test results became positive. This test supports early presumptive diagnosis of tularemia for clinically suspected cases 7-14 days before diagnosis can be confirmed by serologic testing in regions with low prevalences of tularemia-like illnesses.
我们回顾性评估了一种基于流式细胞术的检测方法,该方法可定量检测 CD3+T 细胞中 CD4-/CD8-表型的百分比,以预测 2003-2015 年期间治疗的 64 例疑似和确诊土拉热病例,以及 2012-2015 年期间治疗的 342 例类似土拉热疾病的对照组。外周血中 CD3+/CD4-/CD8-T 细胞的中位数在土拉热患者(19%,95%CI 17%-22%)中高于对照组(3%,95%CI 2%-3%)。当我们使用 8%作为截断值时,该检测对鉴别病例与对照组的敏感性为 0.953,特异性为 0.895。CD3+/CD4-/CD8-T 细胞在土拉热血清学检测结果转为阳性前中位数增加 7 天。在土拉热样疾病流行率较低的地区,该检测可支持对临床疑似病例进行早期推定诊断,可在血清学检测确诊前 7-14 天进行。